Liver senolytics, muscle lipids and AMPK
A phase-2 MASH fibrosis signal, a cardiolipin recovery path, and direct AMPK lifespan gains.
重要的健康与长寿新闻,经过证据核查,并以不夸张的方式解释。没有每日噪音,也没有奇迹承诺。
存档
每一期已发布内容都会保留在这里,可免费打开并轻松分享。请从下方最新一期开始。
A phase-2 MASH fibrosis signal, a cardiolipin recovery path, and direct AMPK lifespan gains.
A blood proxy for senescence burden, an oral bacterium linked to slower aging, and a shared sleep path.
A middle-age trial, a faster path to test longevity drugs, and many healthy eating patterns.
Three September papers on ageing blood markers, organ clocks, and sleep-wave integrity.
Plus a frailty trial, Bhutan's rabies milestone and an Lp(a) outcome miss.
Plus why a refill is not adherence, and what a retraction changes.
Why responsive ageing clocks are signals rather than health verdicts, plus an Alzheimer blood panel and a null stroke-care trial.
52周结果为经同行评审的口服GLP-1研究增添了什么,以及组织衰老、稳定保存的血浆和“结果阶梯”。
我们的筛选器
依据证据解释重要的健康与长寿信息。
依据证据解释重要的健康与长寿信息。
每周二,我们用清晰易读、约五分钟即可读完的内容,聚焦最值得关注的证据。
不夸大的信号
免费,每周二发送。确认一次即可加入。